UFP Technologies to Report Second Quarter 2026 Financial Results on August 3, 2026

UFP Technologies (Nasdaq: UFPT) will report its second quarter 2026 financial results on Monday, August 3, 2026, after the U.S. stock market close.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Conference Call Scheduled for August 4^th at 8:30 AM ET

NEWBURYPORT, Mass.--(BUSINESS WIRE)-- UFP Technologies, Inc. (Nasdaq: UFPT), a trusted contract development and manufacturing organization specializing in comprehensive solutions for medical devices, sterile packaging and other highly engineered custom products, today announced that the Company plans to report results for the second quarter on Monday, August 3^rd, after the close of the stock market. The Company will hold a conference call to discuss the results on the following day, August 4^th, at 8:30 AM Eastern time.

Conference Call Information:

Date: Tuesday, August 4, 2026
Time: 8:30 AM Eastern Time

Participants may join the call using the following dial-in numbers:

• USA/Canada: Toll-Free: 1-412-206-6478
• International: 1-833-890-4010

A live webcast of the conference call and accompanying materials will be available here.

A replay of the webcast will be accessible following the event on the Company’s Investor Relations website at https://ufpt.com/investors/.

About UFP Technologies, Inc.

UFP Technologies is a trusted contract development and manufacturing organization specializing in comprehensive solutions for medical devices, sterile packaging and other highly engineered custom products. The company’s single-use and single-patient devices and components are used across a wide range of medical products in segments including robotic assisted surgery, patient beds, infection control, cardiovascular, orthopedics and spine and wound care. For more information, visit ufpt.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260729601845/en/

Investor Contact:
Jeff Elliott
Three Part Advisors, LLC
214-966-9014

UFP Technologies Contact:
Ron Lataille, CFO
978-234-0926
rlataille@ufpt.com

Source: UFP Technologies, Inc.

Key Terms

contract development and manufacturing organization technical

A contract development and manufacturing organization (CDMO) is a specialized service provider that helps other companies design, test, produce and package drugs or medical products on a hired basis. Think of it as an outsourced factory and R&D partner that lets a company scale production without building its own plants. Investors watch CDMO relationships because they affect a drug’s time-to-market, manufacturing costs, supply reliability and overall project risk, all of which influence future revenue and valuation.

sterile packaging technical

Sterile packaging is packaging designed to keep a medical product free of bacteria, viruses and other living germs until the package is opened, like a sealed lunchbox that guarantees the contents remain clean and safe. For investors it matters because proper sterile packaging is essential for regulatory approval, patient safety and avoiding costly recalls or legal problems, and it can affect manufacturing costs and market access.